Aggressive Angiomyxoma of the Lower Female Genital Tract in Pregnancy: A Review of the MITO Rare Tumors Group.

Autor: Cicogna S; Institute for Maternal and Child Health-IRCCS 'Burlo Garofolo', 34145 Trieste, Italy., Dellino M; Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy., Miano ST; Complex Operating Unit of Oncology, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy., Magazzino F; Complex Operating Unit Ginecologia E Ostetricia, Ospedale Civile Di San Dona' Di Piave (Venezia), Aulss4 Veneto Orientale, 30027 San Donà di Piave, Italy., Domenici L; Division of Obstetrics and Gynecology, Azienda Ospedaliera Universitaria Pisana, University of Pisa, 56126 Pisa, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS 'Fondazione G Pascale', 80144 Napoli, Italy., Mangili G; Obstetrics and Gynecology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy., Cormio G; Department of Interdisciplinary Medicine (DIM), University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy.; Gynecologic Oncology, IRCCS Istituto Tumori 'Giovanni Paolo II', 7012 Bari, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2023 Jun 29; Vol. 15 (13). Date of Electronic Publication: 2023 Jun 29.

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.

Autor: Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy. Electronic address: edoardo.francini@unifi.it., Ou FS; Mayo Clinic, Rochester, MN, USA., Lazzi S; Department of Human Pathology and Oncology, University of Siena, Siena, Italy., Petrioli R; Santa Maria Alle Scotte Hospital, Siena, Italy., Multari AG; Santa Maria Alle Scotte Hospital, Siena, Italy., Pesola G; Santa Maria Alle Scotte Hospital, Siena, Italy., Messuti L; Santa Maria Alle Scotte Hospital, Siena, Italy., Colombo E; Santa Maria Alle Scotte Hospital, Siena, Italy., Livellara V; Santa Maria Alle Scotte Hospital, Siena, Italy., Bazzurri S; Santa Maria Alle Scotte Hospital, Siena, Italy., Cherri S; Santa Maria Alle Scotte Hospital, Siena, Italy., Miano ST; Santa Maria Alle Scotte Hospital, Siena, Italy., Wolfe EG; Mayo Clinic, Rochester, MN, USA., Alberts SR; Mayo Clinic, Rochester, MN, USA., Hubbard JM; Mayo Clinic, Rochester, MN, USA., Yoon HH; Mayo Clinic, Rochester, MN, USA., Francini G; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy.

Publikováno v: Translational oncology [Transl Oncol] 2021 Feb; Vol. 14 (2), pp. 100973. Date of Electronic Publication: 2020 Dec 15.

Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.

Autor: Petrioli R; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy. Electronic address: r.petrioli@ao-siena.toscana.it., Torre P; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Pesola G; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Paganini G; General Medicine& Oncology, Pieve di Coriano Hospital, ASST Mantova, Italy., Paolelli L; Medical Oncology, Vito Fazzi Hospital, Lecce, Italy., Miano ST; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Martellucci I; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Francini G; Medical Oncology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy., Francini E; La Sapienza University, Rome, Italy; Medical Oncology Unit, Misericordia Hospital, Grosseto, Italy.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2020 May; Vol. 11 (4), pp. 647-651. Date of Electronic Publication: 2019 Aug 27.

Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients.

Autor: Palmieri M; Medical Genetics, University of Siena, Siena, Italy., Baldassarri M; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Fava F; Medical Genetics, University of Siena, Siena, Italy.; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Fabbiani A; Medical Genetics, University of Siena, Siena, Italy.; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Gelli E; Medical Genetics, University of Siena, Siena, Italy., Tita R; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Torre P; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Petrioli R; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Hadijstilianou T; Department of Ophthalmology, Referral Center for Retinoblastoma, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Galimberti D; Department of Ophthalmology, Referral Center for Retinoblastoma, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Cinotti E; Department of Medical, Surgical and Neurosciences, Dermatology Unit, University of Siena, Siena, Italy., Bengala C; Medical Oncology, Ospedale Misericordia, Azienda Toscana Sud-Est, Grosseto, Italy., Mandalà M; Department of Otology and Skull Base Surgery, University of Siena, Siena, Italy., Piu P; VisMederi s.r.l, Strada del Petriccio e Belriguardo, Siena, Italy., Miano ST; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Martellucci I; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Vannini A; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Pinto AM; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Mencarelli MA; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Marsili S; Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Renieri A; Medical Genetics, University of Siena, Siena, Italy.; Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy., Frullanti E; Medical Genetics, University of Siena, Siena, Italy.

Publikováno v: Cancer medicine [Cancer Med] 2020 Mar; Vol. 9 (6), pp. 2052-2061. Date of Electronic Publication: 2020 Jan 28.

Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine

Autor: CORREALE P, MIANO ST, REMONDO C, MIGALI C, ROTUNDO MS, MACRÌ P, TAGLIAFERRI P, TASSONE P, GOTTI G, FRANCINI G., CARAGLIA, Michele

Background. The antitumor activity of a novel biweekly gemcitabine (G) + docetaxel (D) regimen +/- granulocyte-macrophage colony stimulating factor (GM-CSF) and aldesleukine (IL-2) has been evaluated in a phase II trial in advanced pretreated non-sma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6bbcbcf96ecf686a0c1d71e9d7be7a8
http://hdl.handle.net/11591/233419